Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Subcuticular suture compared with staples for skin closure after cesarean delivery: A randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of smoking cessation on gestational and postpartum weight gain and neonatal birth weight

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Awareness of endometrial cancer risk and compliance with screening in hereditary nonpolyposis colorectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cytokines and the Risk of Preterm Delivery in Twin Pregnancies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Breech and induction. Time for evidence-based informed consent

    Publikation: Bidrag til tidsskriftLetterpeer review

  2. Using Social Media for Qualitative Health Research in Danish Women of Reproductive Age: Online Focus Group Study on Facebook

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Role of Leptin in Fetal Growth during Pre-Eclampsia

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Rapid Open-Source SNP-Based Clustering Offers an Alternative to Core Genome MLST for Outbreak Tracing in a Hospital Setting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: To investigate the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in parturient women, their partners, and their newborns and the association of such antibodies with obstetric and neonatal outcomes.

METHODS: From April 4 to July 3, 2020, in a single university hospital in Denmark, all parturient women and their partners were invited to participate in the study, along with their newborns. Participating women and partners had a pharyngeal swab and a blood sample taken at admission; immediately after delivery, a blood sample was drawn from the umbilical cord. The swabs were analyzed for SARS-CoV-2 RNA by polymerase chain reaction, and the blood samples were analyzed for SARS-CoV-2 antibodies. Full medical history and obstetric and neonatal information were available.

RESULTS: A total of 1,313 parturient women (72.5.% of all women admitted for delivery at the hospital in the study period), 1,188 partners, and 1,206 newborns participated in the study. The adjusted serologic prevalence was 2.6% in women and 3.5% in partners. Seventeen newborns had SARS-CoV-2 immunoglobulin G (IgG) antibodies, and none had immunoglobulin M antibodies. No associations between SARS-CoV-2 antibodies and obstetric or neonatal complications were found (eg, preterm birth, preeclampsia, cesarean delivery, Apgar score, low birth weight, umbilical arterial pH, need for continuous positive airway pressure, or neonatal admission), but statistical power to detect such differences was low. Full serologic data from 1,051 families showed an absolute risk of maternal infection of 39% if the partner had antibodies.

CONCLUSION: We found no association between SARS-CoV-2 infection and obstetric or neonatal complications. Sixty-seven percent of newborns delivered by mothers with antibodies had SARS-CoV-2 IgG antibodies. A limitation of our study is that we lacked statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.

OriginalsprogEngelsk
TidsskriftObstetrics and Gynecology
Vol/bind137
Udgave nummer1
Sider (fra-til)49-55
Antal sider7
ISSN0029-7844
DOI
StatusUdgivet - 1 jan. 2021

ID: 61406066